Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano Shingo HatakeyamaTomoko HamayaKyo TogashiTeppei OkamotoHayato YamamotoTohru YoneyamaTakahiro YoneyamaYasuhiro HashimotoChikara Ohyama

Published in: IJU case reports (2020)

This case presented that cell-free DNA concentration was possibly correlated with response to castration-resistant prostate cancer treatment and disease progression. Cell-free DNA concentration was proposed as a potential prognostic biomarker of metastatic castration-resistant prostate cancer.

Keyphrases

squamous cell carcinoma
small cell lung cancer
risk assessment
human health
climate change
replacement therapy